Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer.
Journal
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
ISSN: 1527-7755
Titre abrégé: J Clin Oncol
Pays: United States
ID NLM: 8309333
Informations de publication
Date de publication:
20 06 2023
20 06 2023
Historique:
medline:
16
6
2023
pubmed:
24
3
2023
entrez:
23
3
2023
Statut:
ppublish
Résumé
Metastatic castration-resistant prostate cancer (mCRPC) remains a lethal disease with current standard-of-care therapies. Homologous recombination repair (HRR) gene alterations, including MAGNITUDE (ClinicalTrials.gov identifier: NCT03748641) is a phase III, randomized, double-blinded study that evaluates niraparib and abiraterone acetate plus prednisone (niraparib + AAP) in patients with (HRR+, n = 423) or without (HRR-, n = 247) HRR-associated gene alterations, as prospectively determined by tissue/plasma-based assays. Patients were assigned 1:1 to receive niraparib + AAP or placebo + AAP. The primary end point, radiographic progression-free survival (rPFS) assessed by central review, was evaluated first in the Median rPFS in the Combination treatment with niraparib + AAP significantly lengthened rPFS in patients with HRR+ mCRPC compared with standard-of-care AAP. [Media: see text].
Identifiants
pubmed: 36952634
doi: 10.1200/JCO.22.01649
pmc: PMC10431499
doi:
Substances chimiques
Abiraterone Acetate
EM5OCB9YJ6
BRCA1 protein, human
0
niraparib
HMC2H89N35
BRCA1 Protein
0
BRCA2 protein, human
0
BRCA2 Protein
0
Prednisone
VB0R961HZT
Banques de données
ClinicalTrials.gov
['NCT03748641']
Types de publication
Randomized Controlled Trial
Clinical Trial, Phase III
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3339-3351Investigateurs
Maria Alvarez
(M)
Gabriela Gatica
(G)
Martin Greco
(M)
Ernesto Korbenfeld
(E)
Esteban Metrebian
(E)
Jorge Salinas
(J)
Alejandro Salvatierra
(A)
Marcelo Tatangelo
(M)
Tom Ferguson
(T)
Howard Gurney
(H)
Elizabeth Hovey
(E)
Anthony Joshua
(A)
Matos Marco
(M)
Gavin Marx
(G)
Michelle Morris
(M)
Siobhan Ng
(S)
David Pook
(D)
Shahneen Sandhu
(S)
Ali Tafreshi
(A)
Thean Hsiang Tan
(TH)
Tsvetanka Tosheva
(T)
Livia Andrade
(L)
Felipe Cruz
(F)
Luiza Faria
(L)
Jose Figueiredo
(J)
Fabio Franke
(F)
Andrea Juliana Gomes
(AJ)
Ariel Kann
(A)
Celio Kussumoto
(C)
Suelen Martins
(S)
Andre Murad
(A)
Helio Pinczowski
(H)
Giovani Pioner
(G)
Luis Pires
(L)
Daniel Preto
(D)
Gisele Santos
(G)
Eduardo Silva
(E)
Jamile Silva
(J)
Luciano Viana
(L)
Karina Vianna
(K)
Adriano Paula
(A)
Zhiwen Chen
(Z)
Kim Chi
(K)
Urban Emmenegger
(U)
Neil Fleshner
(N)
Sunil Parimi
(S)
Fred Saad
(F)
Francisco Vera-Badillo
(F)
Hongqian Guo
(H)
Hong Luo
(H)
Lulin Ma
(L)
Mingxing Qui
(M)
Wei Xue
(W)
Guo Yonglian
(G)
Lei Li
(L)
Jinxian Pu
(J)
Song Zheng
(S)
Qing Zou
(Q)
Milos Brodak
(M)
Milan Hora
(M)
Vladimir Samal
(V)
Vladimir Student
(V)
Jaroslav Vanasek
(J)
Emmanuelle Bompas
(E)
Philippe Barthelemy
(P)
Delphine Borchiellini
(D)
Aude Flechon
(A)
Hakim Mahammedi
(H)
Guilhem Roubaud
(G)
Antoine Thiery-Vuillemin
(A)
Diego Tosi
(D)
Spaeth Dominique
(S)
Carole Helissey
(C)
Martin Boegemann
(M)
Susan Feyerabend
(S)
Eva Hellmis
(E)
Martin Schostak
(M)
Gerhardt Attard
(G)
Anna Lydon
(A)
Ian Sayers
(I)
Omi Parikh
(O)
Duncan Wheatley
(D)
Peter Arkosy
(P)
Jozsef Erfan
(J)
Lajos Geczi
(L)
Peter Nyirady
(P)
Judit Olah
(J)
Istvan Papos
(I)
Bela Piko
(B)
Raanan Berger
(R)
Avivit Peer
(A)
Umberto Basso
(U)
Sergio Bracarda
(S)
Orazio Caffo
(O)
Francesco Carrozza
(F)
Gianluca Del Conte
(G)
Luca Galli
(L)
Donatello Gasparro
(D)
Sandro Pignata
(S)
Riccardo Ricotta
(R)
Daniele Santini
(D)
Giampaolo Tortora
(G)
Seoksoo Byun
(S)
SeolHo Choo
(S)
ByungHa Chung
(B)
Jaeyoung Joung
(J)
Wonho Jung
(W)
Taek Won Kang
(TW)
Cheol Kwak
(C)
TaeGyun Kwon
(T)
Hyo Jin Lee
(HJ)
Ji Youl Lee
(JY)
SeongIl Seo
(S)
YoungDeuk Choi
(Y)
HongKoo Ha
(H)
ChoungSoo Kim
(C)
Flora Li Tze Chong
(FL)
Chun Sen Lim
(CS)
Vijayan Manogran
(V)
Hwoei Fen Soo Hoo
(HF)
Guan Chou Teh
(GC)
Marniza Saad
(M)
David Calvo Dominguez
(DC)
Abraham Cardenas
(A)
Julia Saenz
(J)
Andre Bergman
(A)
Helgi Helgason
(H)
C B Hunting
(CB)
Rik Somford
(R)
Tomasz Byrski
(T)
Tomasz Drewa
(T)
Dorota Filarska
(D)
Jolanta LuniewskaBury
(J)
Adam Marcheluk
(A)
Konrad Talasiewicz
(K)
Krzysztof Tupikowski
(K)
Renata Zaucha
(R)
Bogdan Zurawski
(B)
Pedro Madeira
(P)
Andre Mansinho
(A)
Nuno Vau
(N)
Anna Alyasova
(A)
Victoria Chistyakova
(V)
Denis Khvorostenko
(D)
Dmitry Kirtbaya
(D)
Gennady Kolesnikov
(G)
Evgeny Kopyltsov
(E)
Igor Lifirenko
(I)
Alexander Lykov
(A)
Konstantin Penkov
(K)
Andrey Semenov
(A)
Mikhail Shkolnik
(M)
Pavel Skopin
(P)
Roman Smirnov
(R)
Evgeny Usynin
(E)
Sergey Varlamov
(S)
Vladimir Vladimirov
(V)
Teresa Alonso
(T)
Sara Breijo
(S)
Elena Castro
(E)
Enrique Gallardo
(E)
Jose Gutierrez Banos
(JG)
Alvaro Juarez
(A)
Rebeca Lozano
(R)
Pablo Maroto
(P)
Javier Puente
(J)
Alejo Rodriguez-Vida
(A)
Regina Girones
(R)
Begona Mellado
(B)
Enrique Castellanos
(E)
Chunde Li
(C)
Chao-Hsiang Chang
(CH)
Hsiao-Jen Chung
(HJ)
Kuan-Hua Huang
(KH)
Yen-Chuan Ou
(YC)
Yu-Chieh Tsai
(YC)
Shian-Shiang Wang
(SS)
Wen-Jeng Wu
(WJ)
See Tong Pang
(ST)
Cagatay Arslan
(C)
Devrim Cabuk
(D)
Hasan Coskun
(H)
Mahmut Gumus
(M)
Mustafa Ozguroglu
(M)
Berna Oksuzoglu
(B)
Berksoy Sahin
(B)
Deniz Tural
(D)
Bulent Yalcin
(B)
Irfan Cicin
(I)
Igor Bondarenko
(I)
Yaroslav Gotsuliak
(Y)
Yevhen Hotko
(Y)
Gennadii Khareba
(G)
Oleksandr Lychkovskyy
(O)
Iryna Lytvyn
(I)
Taron Nalbandyan
(T)
Viktor Paramonov
(V)
Valerii Sakalo
(V)
Eduard Stakhovsky
(E)
Viktor Stus
(V)
Sunil Babu
(S)
Alan Bryce
(A)
David Cahn
(D)
Herta Chao
(H)
Franklin Chu
(F)
Curtis Dunshee
(C)
Oscar Goodman
(O)
Michael Grable
(M)
Jason Hafron
(J)
Joelle Hamilton
(J)
Ralph Hauke
(R)
Joseph Maly
(J)
David Morris
(D)
Gregg Newman
(G)
Patrick Pilie
(P)
Neal Shore
(N)
Paul Sieber
(P)
Matthew Smith
(M)
Andrew Trainer
(A)
Ronald Tutrone
(R)
Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
J Clin Oncol. 2016 Apr 20;34(12):1402-18
pubmed: 26903579
Curr Opin Obstet Gynecol. 2021 Feb 1;33(1):1-6
pubmed: 33369580
J Clin Oncol. 2019 Feb 20;37(6):490-503
pubmed: 30625039
Lancet Oncol. 2019 Dec;20(12):1730-1739
pubmed: 31727538
Oncotarget. 2017 Jun 20;8(25):40222-40232
pubmed: 28410213
Cancer Discov. 2013 Nov;3(11):1245-53
pubmed: 24027196
N Engl J Med. 2018 Apr 12;378(15):1408-1418
pubmed: 29420164
Eur Urol. 2017 Feb;71(2):151-154
pubmed: 27477525
J Clin Oncol. 2020 Nov 10;38(32):3763-3772
pubmed: 32795228
N Engl J Med. 2017 Jul 27;377(4):352-360
pubmed: 28578607
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
N Engl J Med. 2013 Jan 10;368(2):138-48
pubmed: 23228172
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Nat Commun. 2017 Aug 29;8(1):374
pubmed: 28851861
N Engl J Med. 2020 Dec 10;383(24):2345-2357
pubmed: 32955174
Cancer Chemother Pharmacol. 2021 Jul;88(1):25-37
pubmed: 33754187
Eur Urol. 2017 Jul;72(1):34-42
pubmed: 28259476
Lancet Oncol. 2015 Feb;16(2):152-60
pubmed: 25601341
Sci Signal. 2017 May 23;10(480):
pubmed: 28536297
Cancer Discov. 2018 Apr;8(4):444-457
pubmed: 29367197
Ann Oncol. 2021 Jun;32(6):726-735
pubmed: 33794293
Clin Cancer Res. 2021 Mar 15;27(6):1650-1662
pubmed: 33414135
Lancet Oncol. 2022 Mar;23(3):362-373
pubmed: 35131040
Lancet Oncol. 2021 Sep;22(9):1250-1264
pubmed: 34388386
Lancet Oncol. 2012 Oct;13(10):983-92
pubmed: 22995653
Int J Mol Sci. 2019 Mar 22;20(6):
pubmed: 30909387
Cancer Discov. 2012 Dec;2(12):1134-49
pubmed: 22993403
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890